Sanger sequencing, often called the chain-termination method, is a DNA sequencing technology that laid the foundation for modern genomics. Developed by Frederick Sanger in the 1970s, this technique made it possible to read the exact order of nucleotides in a DNA molecule with unprecedented accuracy.
Today, Sanger sequencing remains a trusted method for confirming specific variants, validating next-generation data, and sequencing relatively short targets such as PCR products and plasmid inserts. The following sections detail how the technology works, its workflow, and its practical applications in research and diagnostics.
| Aspect | Key Detail | Impact or Use Case | Typical Range |
|---|---|---|---|
| Method | Chain-termination with dideoxynucleotides | Enables precise identification of each nucleotide position | Deterministic chemistry |
| Read Length | 700–1000 bases per run under optimal conditions | Suitable for short, high-confidence targets | High-quality contiguous sequence |
| Throughput | Low to medium compared to NGS platforms | Ideal for targeted assays and smaller projects | 96 samples per plate in batch workflows |
| Accuracy | 99.99% or higher per base call | Gold standard for confirmatory variant validation | Error rate in low single-digit range |
| Main Applications | Sanger sequencing of PCR products, plasmid maps, Sanger screening | Confirmatory testing, cloning verification, small-scale projects | Core facility and clinical lab routine |
Principles of Sanger Sequencing
At the core of Sanger sequencing is the selective incorporation of chain-terminating dideoxynucleotides (ddNTPs) during DNA synthesis. Because ddNTPs lack a 3'-hydroxyl group, DNA polymerase cannot extend the chain further, producing a set of fragments that end with a specific nucleotide.
When these fragments are separated by size using capillary electrophoresis, the order of termination events is revealed. Fluorescent labels attached to each ddNTP allow the sequence to be read automatically, with a laser detector identifying the color corresponding to the terminal base at every position along the template.
Workflow and Sample Preparation
Sample preparation for Sanger sequencing typically begins with PCR amplification or plasmid miniprep to obtain sufficient, pure DNA. Primers are designed to flank the region of interest and are synthesized to high purity to ensure precise annealing and consistent read quality across runs.
Cycle sequencing reactions combine DNA polymerase, primers, normal deoxynucleotides, and a subset of ddNTBs labeled with distinct fluorophores. Thermal cycling conditions are tuned to favor a balanced distribution of fragment lengths, after which cleanup steps remove excess reagents and salts that could interfere with electrophoresis and detection.
Data Analysis and Interpretation
Electropherogram traces generated by capillary electrophoresis display peak height, spacing, and color corresponding to each base. Dedicated Sanger analysis software aligns these signals to a reference sequence or assembles contiguous reads de novo when no reference is available, enabling clear visualization of variants or mutations.
Quality metrics such as peak symmetry, resolution between close peaks, and uniformity of signal intensity help assess whether the run met acceptance criteria. Analysts routinely inspect electropherograms around heterozygous sites, ambiguous regions, and primer binding areas to confirm that reported genotypes reflect true biological variation rather than technical artifacts.
Applications in Research and Diagnostics
Sanger sequencing is widely used to validate findings from high-throughput platforms, confirm pathogenic variants in clinical genetics, and verify the identity of cloned inserts. Its ability to deliver long, unbroken, high-quality reads makes it particularly valuable for characterizing single genes or small panels where deep coverage and accuracy are non-negotiable.
Regulatory environments often accept Sanger-based data for patient reporting because of its long track record and rigorously understood error profile. Clinical laboratories rely on this method for diagnostic confirmation, while biobanking efforts use it to resolve ambiguous genotyping results from array or NGS screens.
Considerations for Laboratory Implementation
Implementing Sanger sequencing requires careful attention to primer design, PCR conditions, and electrophoresis parameters to maintain reproducibility across batches. Laboratories must also establish clear workflows for sample tracking, chain-termination reactions, and data analysis pipelines to ensure that every step meets documented quality standards.
Although throughput is lower than that of next-generation platforms, Sanger sequencing offers an attractive cost-per-target model for small projects, targeted validation, and regulatory submissions that demand a well-characterized technology. Routine maintenance of instrumentation, calibration of capillaries, and periodic audits of reagent performance help sustain consistent results over time.
Key Takeaways and Recommendations
- Use Sanger sequencing for high-confidence validation of targeted variants and small projects
- Design primers carefully to avoid secondary structures and ensure uniform coverage
- Follow standardized protocols for sample prep, cycle sequencing, and data analysis
- Leverage Sanger data to confirm NGS findings and support regulatory submissions
- Monitor instrument calibration and reagent performance to maintain reproducibility
FAQ
Reader questions
What types of samples are suitable for Sanger sequencing?
PCR products, plasmid DNA, bacterial artificial chromosome clones, and other purified DNA templates with minimal inhibitors are ideal. Sample purity and concentration must meet specified thresholds to avoid ambiguous electropherograms or reduced read quality.
How does Sanger sequencing compare to next-generation sequencing for targeted analysis?
Sanger sequencing provides higher accuracy and longer, contiguous reads for targeted assays, whereas next-generation sequencing offers higher throughput for screening multiple genes or detecting low-frequency variants. Researchers often use Sanger to confirm variants identified by NGS when precise nucleotide-level validation is required.
Can Sanger sequencing be used to detect low-frequency variants in a mixed sample?
Standard Sanger sequencing has limited sensitivity for low-frequency alleles, typically above 15–20% variant fraction. Highly sensitive methods or deep sequencing approaches are preferred when detecting rare subclones or minimal residual disease is the goal.
What are the main sources of error in Sanger sequencing data?
Errors can arise from poor primer design, secondary structures in the template, stutter or peak overlap in electropherograms, and incorporation errors by DNA polymerase. Rigorous laboratory practices, appropriate quality metrics, and comparison to orthogonal methods help minimize and detect such artifacts.